Attovia Therapeutics, Inc.(ATTO)
$16.73+0.09 (+0.54%)
ATTO
Attovia Therapeutics, Inc. financials statements
$16.73
At close:+0.09 (+0.54%)
Want to see ATTO full AI Analyst Report?
Attovia Therapeutics, Inc. (ATTO) Financial Statements
13 Followers
Attovia Therapeutics, Inc. Financial Overview
Attovia Therapeutics, Inc.'s market cap is currently $760.66M. The company's EPS TTM is $-1.69; its P/E ratio is -8.45; and it has a dividend yield of 3.40%. Attovia Therapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.35M | $ 0.00 | $ 1.45B | $ 1.41B | $ 1.71B |
| Gross Profit | $ 546.00K | $ -313.00K | $ 1.36B | $ 1.34B | $ 1.64B |
| Operating Income | $ -67.16M | $ -41.55M | $ 72.50M | $ 56.00M | $ 63.60M |
| EBITDA | $ -66.36M | $ -41.24M | $ 232.70M | $ 176.90M | $ 204.40M |
| Net Income | $ -60.63M | $ -39.80M | $ -90.20M | $ -46.80M | $ -80.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 152.27M | $ 69.32M | $ 129.57M | $ 210.15M | $ 125.80M |
| Total Assets | $ 165.89M | $ 76.72M | $ 1.10B | $ 1.19B | $ 1.32B |
| Total Debt | $ 5.26M | $ 0.00 | $ 718.28M | $ 726.58M | $ 720.61M |
| Net Debt | $ -34.93M | $ -30.63M | $ 589.46M | $ 517.59M | $ 595.91M |
| Total Liabilities | $ 15.10M | $ 14.59M | $ 1.11B | $ 1.07B | $ 1.12B |
| Stockholders' Equity | $ 150.79M | $ 62.13M | $ -10.19M | $ 119.09M | $ 207.02M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.51M | $ -36.81M | $ -5.80M | $ 90.00M | $ 6.30M |
| Operating Cash Flow | $ -59.20M | $ -35.03M | $ 42.30M | $ 128.20M | $ 46.40M |
| Investing Cash Flow | $ -73.45M | $ -39.80M | $ -50.50M | $ -38.20M | $ -56.00M |
| Financing Cash Flow | $ 142.01M | $ 82.75M | $ -58.20M | $ -300.00K | $ 5.10M |
Currency in USD
